fluorobenzenes has been researched along with Breast Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ST; Ho, CT; Kuo, SC; Liu, LC; Way, TD; Wu, YC | 1 |
| Calléja, FMGR; Devilee, P; Hendriks, G; Mesman, RLS; Misovic, B; Morolli, B; van Asperen, CJ; Vreeswijk, MPG; Vrieling, H | 1 |
| Aamer, M; Crivianu-Gaita, V; Posaratnanathan, RT; Romaschin, A; Thompson, M | 1 |
| Ashworth, A; Lord, CJ; McDonald, S; Swift, S; Turner, NC | 1 |
| Goyal, S; Haffty, BG; Taunk, NK | 1 |
| Clarke, AR; Hay, T; Jenkins, H; Martin, NM; Sansom, OJ; Smith, GC | 1 |
| Grimm, S; Huang, L; Wang, Y | 1 |
| Rikhe, K | 1 |
| Arndt, A; Rieche, K | 1 |
9 other study(ies) available for fluorobenzenes and Breast Neoplasms
| Article | Year |
|---|---|
2-Phenylnaphthyridin-4-one Derivative LYF-11 Inhibits Interleukin-6-mediated Epithelial-to-Mesenchymal Transition
Topics: Antineoplastic Agents; Breast Neoplasms; Epithelial-Mesenchymal Transition; Fluorobenzenes; Humans; Interleukin-6; Janus Kinase 2; MCF-7 Cells; Naphthyridines; Quinolones; Signal Transduction; STAT3 Transcription Factor | 2018 |
The functional impact of variants of uncertain significance in BRCA2.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Cell Cycle; Cells, Cultured; Cisplatin; Fluorobenzenes; Genes, BRCA2; Genetic Complementation Test; Genetic Variation; Humans; Mice; Mouse Embryonic Stem Cells; Mutation, Missense; Phthalazines; Poly(ADP-ribose) Polymerase Inhibitors; Real-Time Polymerase Chain Reaction; Transfection | 2019 |
Acoustic wave biosensor for the detection of the breast and prostate cancer metastasis biomarker protein PTHrP.
Topics: Animals; Antibodies, Immobilized; Biosensing Techniques; Breast Neoplasms; Cattle; Female; Fluorobenzenes; Humans; Immunoglobulin Fab Fragments; Male; Neoplasm Metastasis; Parathyroid Hormone-Related Protein; Phenols; Photoelectron Spectroscopy; Prostatic Neoplasms; Serum Albumin, Bovine; Sound | 2016 |
A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity.
Topics: Blotting, Western; Breast Neoplasms; DNA Repair; DNA Repair Enzymes; Fluorobenzenes; Humans; Phthalazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quality Control; Reproducibility of Results; RNA, Small Interfering; Sensitivity and Specificity; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2008 |
Radiation recall 5 years after whole-breast irradiation for early-stage breast cancer secondary to initiation of rosuvastatin and amlodipine.
Topics: Amlodipine; Anti-Bacterial Agents; Antihypertensive Agents; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cellulitis; Diagnosis, Differential; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Pyrimidines; Radiodermatitis; Radiotherapy, Adjuvant; Rosuvastatin Calcium; Sulfonamides; Time Factors | 2011 |
Efficient deletion of normal Brca2-deficient intestinal epithelium by poly(ADP-ribose) polymerase inhibition models potential prophylactic therapy.
Topics: Animals; Apoptosis; Biological Availability; BRCA2 Protein; Breast Neoplasms; DNA Damage; Enzyme Inhibitors; Fluorobenzenes; Gene Deletion; Genes, BRCA2; Intestinal Mucosa; Intestine, Small; Mice; Mice, Transgenic; Phthalazines; Poly(ADP-ribose) Polymerase Inhibitors | 2005 |
ATP-dependent transport of rosuvastatin in membrane vesicles expressing breast cancer resistance protein.
Topics: Adenosine Triphosphate; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport, Active; Breast Neoplasms; Cell Line, Tumor; Cytoplasmic Vesicles; Drug Resistance, Neoplasm; Female; Fluorobenzenes; Humans; Kinetics; Mitochondrial Proteins; Multidrug Resistance-Associated Protein 2; Neoplasm Proteins; Pyrimidines; Ribosomal Proteins; Rosuvastatin Calcium; Saccharomyces cerevisiae Proteins; Subcellular Fractions; Sulfonamides | 2006 |
[The influence of chemotherapy on delayed allergy in patients with malignant tumors].
Topics: Antigens; Antineoplastic Agents; Benzene Derivatives; Bleomycin; Breast Diseases; Breast Neoplasms; Cyclophosphamide; Drug Combinations; Female; Fluorobenzenes; Hodgkin Disease; Humans; Hydrazones; Hypersensitivity, Delayed; Immune System Diseases; Immunity, Cellular; Leukemia; Lung Neoplasms; Methotrexate; Multiple Myeloma; Neoplasms; Nitrobenzenes; Olivomycins; Skin; Stomach Neoplasms; Triaziquone; Tuberculin; Vinblastine | 1973 |
[The effect of the clinically usual cytostatic therapy on cell-mediated immune reactions in tumor patients].
Topics: Breast Neoplasms; Bronchial Neoplasms; Cell Migration Inhibition; Cyclophosphamide; Drug Therapy, Combination; Fluorobenzenes; Fluorouracil; Immunization; Leukemia, Lymphoid; Macrophages; Multiple Myeloma; Neoplasms; Nitrobenzenes; Tuberculin Test | 1973 |